Testing gene editing techniques in pigs
Official title: Swine Somatic Cell Gene Editing Testing Center
Funded at University of Missouri-Columbia · NIH-10928238 · Data updated 2026-11-12
This study is all about helping scientists create and test new gene editing techniques using pigs, which can lead to better treatments for health conditions, and it’s designed for researchers who want to explore these exciting possibilities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 12, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,329,621 |
| NIH project number | 5U42OD035738-02 |
| Project ID | NIH-10928238 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would be those involved in or affected by conditions that could benefit from somatic cell genome editing therapies.
✕Less likely to help
Patients who are not involved in gene therapy research or do not have conditions targeted by somatic cell genome editing may not benefit from this research.
What this research studies
This research focuses on providing essential services to the somatic cell genome editing community by producing and supplying swine biomedical models. It evaluates the safety and effectiveness of various gene editing strategies and aims to determine their therapeutic value and timing. The project also involves managing communication and logistics for researchers, ensuring that innovative gene editing methods can be tested and potentially translated into clinical applications. By maintaining breeding colonies and specialized facilities, the research supports the development of new therapies.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in gene therapies that may improve treatment options for various diseases.
How similar studies have gone: Other research in gene editing has shown promising results, indicating that this approach has the potential for significant breakthroughs in medical treatment.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Wells, Kevin Dale — University of Missouri-Columbia
- Study coordinator: Wells, Kevin Dale
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.